Growth Metrics

Oruka Therapeutics (ORKA) Change in Account Payables (2010 - 2026)

Oruka Therapeutics' quarterly Change in Account Payables came in at -$493000.0 in Q1 2026, down 693.98% year-on-year from $83000.0 in Q1 2025, and up 89.64% quarter-over-quarter from -$4.8 million in Q4 2025.

Oruka Therapeutics has reported Change in Account Payables for 17 years, with the latest figure at -$493000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Change in Account Payables fell 693.98% year-over-year to -$493000.0; the trailing twelve-month figure through Mar 2026 stood at -$6.6 million (down 2504.74% YoY), and the FY2025 full-year result was -$6.0 million, down 199.85% from the prior year.
  • Change in Account Payables for Q1 2026 stood at -$493000.0, up from -$4.8 million in the prior quarter.
  • The five-year high for Change in Account Payables was $5.8 million in Q1 2024, with the low at -$6.0 million in Q2 2025.
  • Average Change in Account Payables over 5 years is -$72882.4, with a median of -$103000.0 recorded in 2022.
  • Year-over-year, Change in Account Payables sank 4216.67% in 2022 and jumped 18121.88% in 2024.
  • Tracing ORKA's Change in Account Payables over 5 years: stood at -$259000.0 in 2022, then jumped by 115.44% to $40000.0 in 2023, then soared by 10902.5% to $4.4 million in 2024, then sank by 208.13% to -$4.8 million in 2025, then surged by 89.64% to -$493000.0 in 2026.
  • The last three Change in Account Payables figures came in at -$493000.0 (Q1 2026), -$4.8 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -3.26 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 35.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Oruka Therapeutics 3.04 Bn 2.65 Bn - -493,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -493,000.00
Mar 31, 2026 -493,000.00
Dec 31, 2025 -4.76 Mn
Dec 31, 2025 -4.76 Mn
Sep 30, 2025 4.65 Mn
Sep 30, 2025 4.65 Mn
Jun 30, 2025 -5.99 Mn
Jun 30, 2025 -5.99 Mn
Mar 31, 2025 83,000.00
Mar 31, 2025 83,000.00
Dec 31, 2024 4.40 Mn
Dec 31, 2024 4.40 Mn
Sep 30, 2024 -401,000.00
Sep 30, 2024 -401,000.00
Jun 30, 2024 -3.81 Mn
Jun 30, 2024 -3.81 Mn
Mar 31, 2024 5.83 Mn
Mar 31, 2024 5.83 Mn
Dec 31, 2023 40,000.00
Dec 31, 2023 40,000.00
Sep 30, 2023 81,000.00
Sep 30, 2023 81,000.00
Jun 30, 2023 -125,000.00
Jun 30, 2023 -125,000.00
Mar 31, 2023 32,000.00
Mar 31, 2023 32,000.00
Dec 31, 2022 -259,000.00
Dec 31, 2022 -259,000.00
Sep 30, 2022 -517,000.00
Sep 30, 2022 -517,000.00
Jun 30, 2022 96,000.00
Jun 30, 2022 96,000.00
Mar 31, 2022 -103,000.00
Mar 31, 2022 -103,000.00
Dec 31, 2021 -6,000.00
Dec 31, 2021 -6,000.00
Sep 30, 2021 -1.07 Mn
Sep 30, 2021 -1.07 Mn
Jun 30, 2021 605,000.00
Jun 30, 2021 605,000.00
Mar 31, 2021 56,000.00
Mar 31, 2021 56,000.00
Dec 31, 2020 1.02 Mn
Dec 31, 2020 1.02 Mn
Sep 30, 2020 186,000.00
Sep 30, 2020 186,000.00
Jun 30, 2020 190,000.00
Jun 30, 2020 190,000.00
Mar 31, 2020 -293,000.00
Mar 31, 2020 -293,000.00
Dec 31, 2019 283,000.00
Dec 31, 2019 283,000.00
Sep 30, 2019 -82,000.00
Sep 30, 2019 -82,000.00
Jun 30, 2019 -11,000.00
Jun 30, 2019 -11,000.00
Mar 31, 2019 -2,000.00
Mar 31, 2019 -2,000.00
Dec 31, 2018 13,000.00
Dec 31, 2018 13,000.00
Sep 30, 2018 -188,000.00
Sep 30, 2018 -188,000.00
Jun 30, 2018 -203,000.00
Jun 30, 2018 -203,000.00
Mar 31, 2018 -14,000.00
Mar 31, 2018 -14,000.00
Dec 31, 2017 -612,000.00
Dec 31, 2017 -612,000.00
Sep 30, 2017 170,000.00
Sep 30, 2017 170,000.00
Jun 30, 2017 93,000.00
Jun 30, 2017 93,000.00
Mar 31, 2017 -234,000.00
Mar 31, 2017 -234,000.00
Dec 31, 2016 193,000.00
Dec 31, 2016 193,000.00
Sep 30, 2016 257,000.00
Sep 30, 2016 257,000.00
Jun 30, 2016 11,000.00
Jun 30, 2016 11,000.00
Mar 31, 2016 380,000.00
Mar 31, 2016 380,000.00
Dec 31, 2015 -264,000.00
Dec 31, 2015 -264,000.00
Sep 30, 2015 31,000.00
Sep 30, 2015 31,000.00
Jun 30, 2015 -54,000.00
Jun 30, 2015 -54,000.00
Mar 31, 2015 -144,000.00
Mar 31, 2015 -144,000.00
Dec 31, 2014 430,000.00
Dec 31, 2014 430,000.00
Sep 30, 2014 -360,000.00
Sep 30, 2014 -360,000.00
Jun 30, 2014 173,000.00
Jun 30, 2014 173,000.00
Mar 31, 2014 -45,000.00
Mar 31, 2014 -45,000.00
Dec 31, 2013 150,000.00
Dec 31, 2013 150,000.00
Sep 30, 2013 60,000.00
Sep 30, 2013 60,000.00
Jun 30, 2013 10,000.00
Jun 30, 2013 10,000.00
Mar 31, 2013 312,000.00
Mar 31, 2013 312,000.00
Dec 31, 2012 -54,000.00
Dec 31, 2012 -54,000.00
Sep 30, 2012 -107,000.00
Sep 30, 2012 -107,000.00
Jun 30, 2012 100,000.00
Jun 30, 2012 100,000.00
Mar 31, 2012 -134,000.00
Mar 31, 2012 -134,000.00
Dec 31, 2011 -24,000.00
Dec 31, 2011 -24,000.00
Sep 30, 2011 -233,000.00
Sep 30, 2011 -233,000.00
Jun 30, 2011 -194,000.00
Jun 30, 2011 -194,000.00
Mar 31, 2011 323,000.00
Mar 31, 2011 323,000.00
Dec 31, 2010 119,000.00
Dec 31, 2010 119,000.00
Sep 30, 2010 -10,000.00
Sep 30, 2010 -10,000.00